Ongoing Developments and Barriers for Treatment of Alzheimer Disease
August 23rd 2021It is the responsibility of the pharmacist to remain informed of all existing and new drugs for the treatment of Alzheimer disease, especially because novel and investigational drugs may target the pathophysiology of the disease.
Read More